comparemela.com
Home
Live Updates
First Gene Therapy for Hemophilia B, CSLs HEMGENIX®, Approved by the European Commission : comparemela.com
First Gene Therapy for Hemophilia B, CSL's HEMGENIX®, Approved by the European Commission
/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) today announced that the European Commission has granted conditional marketing authorization (CMA)...
Related Keywords
Germany
,
Norway
,
Australia
,
Iceland
,
Liechtenstein
,
United Kingdom
,
Frankfurt
,
Brandenburg
,
Stephanie Fuchs
,
Wolfgang Miesbach
,
Greg Healy
,
Kim Odonohue
,
Lutz Bonacker
,
Jimmy Baker
,
Care Center
,
Twitter
,
European Commission
,
Regulatory Agency
,
European Union
,
University Hospital Of Frankfurt
,
European Medicines Agency
,
Committee For Medicinal Products Human Use
,
Head Of Research Development
,
European Economic Area
,
Bill Mezzanotte
,
Chief Medical Officer
,
Medicinal Products
,
Human Use
,
Professor Wolfgang Miesbach
,
Coagulation Disorders
,
Comprehensive Care Center
,
University Hospital
,
Senior Vice President
,
General Manager
,
Commercial Operations Europe
,
Drug Administration
,
Annual Bleeding Rate
,
First Gene
,
Annual Congress
,
Latest Clinical Trial Results Session
,
Csl
,
comparemela.com © 2020. All Rights Reserved.